日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

VIKTORIA-1 Trial of Gedatolisib Plus Fulvestrant With or Without Palbociclib in Hormone Receptor-Positive/HER2-/PIK3CA Wild-Type Advanced Breast Cancer

VIKTORIA-1试验:Gedatolisib联合Fulvestrant,加或不加Palbociclib治疗激素受体阳性/HER2-/PIK3CA野生型晚期乳腺癌

Hurvitz, Sara A; Layman, Rachel M; Curigliano, Giuseppe; André, Fabrice; Cristofanilli, Massimo; Kim, Sung-Bae; Martínez Rodríguez, Jorge Luis; Nadal, Jorge C; Kim, Gun Min; Lo, Louisa; Remolina-Bonilla, Yuly A; Rosselli, Geronimo; Emile, George; Korbenfeld, Ernesto; Puig, Juan Manuel; Wesolowski, Robert; Martin, Miguel; Ring, Alistair; Han, Hyo S; Giordano, Antonio; Mutka, Sarah C; Moss, Keren; Suzuki, Sam; Sullivan, Brian; Gorbatchevsky, Igor; Pistilli, Barbara

"We Don't Know What to Do With an Adult" A Qualitative Study of Cerebral Palsy Transition Gaps

“我们不知道该如何对待成年人”:一项关于脑瘫过渡差距的定性研究

Sarmiento, Cristina A; Glaros, Chloe; Petranovich, Christine; Friedman, Hannah; Feinstein, James; Hurvitz, Edward; Morris, Megan A; Brenner, Lisa A; Dorsey, Brooke

A feasibility open-label clinical trial utilizing second-generation artificial intelligence based on the constrained-disorder principle in patients with Parkinson's disease

一项利用基于约束障碍原理的第二代人工智能治疗帕金森病患者的可行性开放标签临床试验

Lehmann, Hillel; Azmanov, Henny; Hershkovitz, Yoav; Hurvitz, Noa; Agus, Samuel; Berg, Marc; Arkadir, David; Ilan, Yaron

The therapeutic window: timing dentoalveolar surgery to minimize MRONJ risk in denosumab-treated osteoporotic patients

治疗窗口:选择合适的时机进行牙槽外科手术,以最大程度降低接受地诺单抗治疗的骨质疏松患者发生颌骨坏死的风险

Masri, Daya; Rosenfeld, Eli; Adut, Shaked; Chaushu, Gavriel; Tsvetov, Gloria; Avishai, Gal; Ghanaiem, Omar; Jonas, Ehud; Zlotogorski-Hurvitz, Ayelet; Muchnik, Daniel

Ribociclib Plus Endocrine Therapy in Hormone Receptor-Positive/ERBB2-Negative Early Breast Cancer: 4-Year Outcomes From the NATALEE Randomized Clinical Trial

瑞博西尼联合内分泌治疗激素受体阳性/ERBB2阴性早期乳腺癌:NATALEE随机临床试验的4年结果

Fasching, Peter A; Stroyakovskiy, Daniil; Yardley, Denise A; Huang, Chiun-Sheng; Crown, John; Bardia, Aditya; Chia, Stephen; Im, Seock-Ah; Martin, Miguel; Xu, Binghe; Loi, Sherene; Barrios, Carlos; Untch, Michael; Moroose, Rebecca; Visco, Frances; Hortobagyi, Gabriel N; Slamon, Dennis J; Fresco, Rodrigo; Zarate, Juan Pablo; Li, Zheng; Waters, Sorcha; Hurvitz, Sara A

Physio-fUS: a tissue-motion based method for heart and breathing rate assessment in neurofunctional ultrasound imaging

Physio-fUS:一种基于组织运动的神经功能超声成像心率和呼吸频率评估方法

Zucker, Nicolas; Le Meur-Diebolt, Samuel; Cybis Pereira, Felipe; Baranger, Jérôme; Hurvitz, Isabella; Demené, Charlie; Osmanski, Bruno-Félix; Ialy-Radio, Nathalie; Biran, Valérie; Baud, Olivier; Pezet, Sophie; Deffieux, Thomas; Tanter, Mickael

A First-in-Human Study of Cinrebafusp Alfa, a HER2/4-1BB Bispecific Molecule, in Patients with HER2-Positive Advanced Solid Malignancies

Cinrebafusp Alfa(一种 HER2/4-1BB 双特异性分子)在 HER2 阳性晚期实体恶性肿瘤患者中的首次人体研究

Piha-Paul, Sarina; Olwill, Shane A; Hamilton, Erika; Tolcher, Anthony; Pohlmann, Paula; Liu, Stephen V; Wurzenberger, Cornelia; Hasenkamp, Laura-Carolin; Hansbauer, Eva-Maria; Shroff, Rachna; Hurvitz, Sara; Krishnamurthy, Anuradha; Patnaik, Amita; Hahn, Noah; Kumar, Raman; Duerr, Manuela; Zettl, Markus; Aviano, Kayti; Matis, Louis; Bruns, Ingmar; Ku, Geoffrey

Health-Related Quality of Life in Patients with HR+/HER2- Early Breast Cancer Treated with Ribociclib Plus a Nonsteroidal Aromatase Inhibitor: Results from the NATALEE Trial

接受瑞博西尼联合非甾体类芳香化酶抑制剂治疗的 HR+/HER2- 早期乳腺癌患者的健康相关生活质量:NATALEE 试验结果

Fasching, Peter A; Slamon, Dennis; Nowecki, Zbigniew; Kukielka-Budny, Bozena; Stroyakovskiy, Daniil; Yardley, Denise A; Huang, Chiun-Sheng; Chan, Arlene; Chia, Stephen; Martín, Miguel; Rugo, Hope S; Loi, Sherene; Hurvitz, Sara; Untch, Michael; Afenjar, Karen; Fresco, Rodrigo; Danyliv, Andriy; Ferrusi, Ilia; Li, Zheng; Hortobagyi, Gabriel

Cardiotoxic Effects of Antibody Drug Conjugates vs Standard Chemotherapy in ERBB2-Positive Advanced Breast Cancer: A Systematic Review and Meta-Analysis

抗体药物偶联物与标准化疗在ERBB2阳性晚期乳腺癌中的心脏毒性作用:系统评价和荟萃分析

Seth, Lakshya; Bhave, Aditya; Kollapaneni, Sai; Shah, Viraj; Nahle, Tarek; Blaes, Anne; Dent, Susan; Hurvitz, Sara A; Guha, Avirup

The association of high body mass index with the safety and efficacy of sacituzumab govitecan in patients with metastatic triple-negative breast cancer from the ASCENT study

ASCENT 研究显示,高体重指数与 sacituzumab govitecan 在转移性三阴性乳腺癌患者中的安全性和有效性相关

García-Estévez, L; Bardia, A; Rugo, H S; Carey, L A; Diéras, V C; Loibl, S; Piccart, M; Gianni, L; Kalinsky, K; O'Shaughnessy, J; Hurvitz, S A; Harting, E; Valdez, T; Phan, S; Lai, C; Cortés, J